CanChew Biotechnologies focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products through the development of MedChewRX®. The company targets research and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum-based products in their respective fields e.g: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms.
CanChew Biotech has a patent-pending technology which comprises the inclusion of regulatory acceptable active pharmaceutical ingredients [API] of the cannabinoid variety in a patent-pending and proprietary chewing gum delivery formulation.
The MedChewRX® formulation offers a unique, socially acceptable, patient friendly, taste masked and convenient delivery format for delivery of the cannabis/cannabinoid(s) based medicine via the oral mucosal membranes.
MedChewRX's full oral-oropharyngeal mucous membrane delivery method is superior to other delivery methods.
Advantages of Oral-Mucosal Drug Delivery system:
4901 Morena Blvd., Suite 701